Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

What specific seizure types does stiripentol treat unlike fenfluramine?

See the DrugPatentWatch profile for stiripentol

  • Stiripentol: Approved for Dravet syndrome and used as an add‑on with clobazam and valproate. It has broad activity across multiple seizure types seen in Dravet, including generalized tonic-clonic seizures, myoclonic seizures, focal seizures, and drop attacks (atonic seizures). In practice, it’s used to help with the overall seizure burden in Dravet.

  • Fenfluramine: Also approved for Dravet (and for Lennox-Gastaut in some settings), but its documented effect is strongest on convulsive seizures. It mainly reduces convulsive seizures (generalized tonic-clonic and other convulsive seizures) rather than non-convulsive or non‑convulsive seizure types.

    So, the key difference is that stiripentol is used for a broader range of seizure types in Dravet, while fenfluramine is more specifically focused on reducing convulsive seizures. If you’re considering treatment options, discuss with a clinician to see which seizure types are most relevant for the individual patient.


Other Questions About Stiripentol :

Can stiripentol be a cost effective fenfluramine alternative? How does stiripentol's effectiveness differ from fenfluramine's in seizure control? How does stiripentol compare to fenfluramine in reducing seizure frequency? Can stiripentol provide better seizure control than fenfluramine? What are common reasons for stiripentol prescription instead of fenfluramine? What patient group benefits most from stiripentol treatment? How does stiripentol's mechanism differ from fenfluramine in treating resistant seizures?